NO20010861L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20010861L
NO20010861L NO20010861A NO20010861A NO20010861L NO 20010861 L NO20010861 L NO 20010861L NO 20010861 A NO20010861 A NO 20010861A NO 20010861 A NO20010861 A NO 20010861A NO 20010861 L NO20010861 L NO 20010861L
Authority
NO
Norway
Prior art keywords
new connections
prevention
formula
treatment
acceptable salts
Prior art date
Application number
NO20010861A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010861D0 (no
Inventor
Amin Kosrat
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20010861D0 publication Critical patent/NO20010861D0/no
Publication of NO20010861L publication Critical patent/NO20010861L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20010861A 1998-08-21 2001-02-20 Nye forbindelser NO20010861L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001401 WO2000010999A2 (fr) 1998-08-21 1999-08-18 Nouveaux composes

Publications (2)

Publication Number Publication Date
NO20010861D0 NO20010861D0 (no) 2001-02-20
NO20010861L true NO20010861L (no) 2001-04-10

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010861A NO20010861L (no) 1998-08-21 2001-02-20 Nye forbindelser

Country Status (22)

Country Link
US (1) US6613775B1 (fr)
EP (1) EP1105390B1 (fr)
JP (1) JP2002523414A (fr)
KR (1) KR20010072797A (fr)
CN (1) CN1161355C (fr)
AR (1) AR020225A1 (fr)
AT (1) ATE242242T1 (fr)
AU (1) AU770511B2 (fr)
BR (1) BR9913102A (fr)
CA (1) CA2339372A1 (fr)
DE (1) DE69908608T2 (fr)
DK (1) DK1105390T3 (fr)
ES (1) ES2201769T3 (fr)
HK (1) HK1036274A1 (fr)
IL (1) IL141165A0 (fr)
MY (1) MY121387A (fr)
NO (1) NO20010861L (fr)
NZ (1) NZ509744A (fr)
PT (1) PT1105390E (fr)
SE (1) SE9802793D0 (fr)
WO (1) WO2000010999A2 (fr)
ZA (1) ZA200100911B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR101179012B1 (ko) 2003-03-10 2012-09-03 니코메드 게엠베하 로플루미라스트 신규한 제조 방법
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005026164A1 (fr) * 2003-09-18 2005-03-24 Altana Pharma Ag Imidazo[4,5-c]pyridines a activite pharmacologique
EP1682133A1 (fr) 2003-11-03 2006-07-26 AstraZeneca AB Derives d'imidazo 1,2-a pydirine pour le traitement du reflux gastro-oesophagien sans douleur
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1776361A1 (fr) * 2004-08-02 2007-04-25 Altana Pharma AG 1h-pyrroloý3,2-b¨pyridines 5-substituees
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
AU2006224619B2 (en) 2005-03-16 2012-06-07 Takeda Gmbh Taste masked dosage form containing roflumilast
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ（１，２−ａ）ピリジン誘導体
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
US8648080B2 (en) 2009-07-09 2014-02-11 Raqualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
MY121387A (en) 2006-01-28
AU770511B2 (en) 2004-02-26
US6613775B1 (en) 2003-09-02
CA2339372A1 (fr) 2000-03-02
AR020225A1 (es) 2002-05-02
DK1105390T3 (da) 2003-09-22
CN1161355C (zh) 2004-08-11
JP2002523414A (ja) 2002-07-30
HK1036274A1 (en) 2001-12-28
CN1323308A (zh) 2001-11-21
DE69908608T2 (de) 2004-04-29
ATE242242T1 (de) 2003-06-15
ES2201769T3 (es) 2004-03-16
IL141165A0 (en) 2002-11-10
AU5767899A (en) 2000-03-14
SE9802793D0 (sv) 1998-08-21
DE69908608D1 (de) 2003-07-10
ZA200100911B (en) 2002-05-02
EP1105390B1 (fr) 2003-06-04
WO2000010999A2 (fr) 2000-03-02
BR9913102A (pt) 2001-05-08
NZ509744A (en) 2003-05-30
PT1105390E (pt) 2003-10-31
WO2000010999A3 (fr) 2000-06-02
NO20010861D0 (no) 2001-02-20
KR20010072797A (ko) 2001-07-31
EP1105390A2 (fr) 2001-06-13

Similar Documents

Publication Publication Date Title
NO20010860L (no) Nye forbindelser
NO20010861L (no) Nye forbindelser
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
TR200100805T2 (tr) Tetrahidropiridoeterler
SE9700661D0 (sv) New compounds
NO20071534L (no) Behandling av inflammatoriske forstyrrelser og smerte
CA2256687A1 (fr) Derives de benzimidazole pour traiter les maladies inflammatoires gastro-intestinales
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO954928D0 (no) Nye aktive forbindelser
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
MY140718A (en) Novel imidazopyridine compound ii with therapeutic effect
SE0202280D0 (sv) Novel compounds
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
NO20072340L (no) Difluorsubstituerte Imidazopyridiner
AR044854A1 (es) Compuesto de imidazopiridina
ATE382616T1 (de) Neue verbindungen
NO921691L (no) Farmasoeytisk preparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application